RESOLV / USDT

RESOLV / TRY

RESOLV / USDC

CHZ / BTC

ACH / BTC

WIF / BTC

PIVX / BTC

DUSK / USDT

MOVE / BNB

NIL / USDC

WCT / USDC

WCT / USDT

WCT / TRY

WCT / FDUSD

WCT / BNB

XNO / USDT

DASH / USDT

DASH / USDC

AWE / USDT

STRK / USDT

PHYSICSWALLAH LIMITED

SECUREKLOUD TECH LIMITED

ENERGY DEVE. CO.LTD

FAIRCHEM ORGANICS LIMITED

UNIHEALTH HOSPITALS LTD

5PAISA CAPITAL LIMITED

INDIAN EMULSIFIERS LTD

WELSPUN INV & COMM LTD

PANSARI DEVELOPERS LTD

FAZE THREE LIMITED

ATAL REALTECH LIMITED

ARC INSULATION & INSU LTD

BLUE PEBBLE LIMITED

FISCHER MEDICAL VENTURE L

RHETAN TMT LIMITED

QUICKTOUCH TECHNOLOGIES L

SAHANA SYSTEM LIMITED

GABRIEL INDIA LTD

ISHAN INTERNATIONAL LTD

REPRO INDIA LIMITED

Click here to get full coverage on India's Emcure Pharmaceuticals drops after block deals at discount - TradingView

India's Emcure Pharmaceuticals drops after block deals at discount  TradingView

India's Emcure Pharmaceuticals drops after block deals at discount - TradingView

Click here to get full coverage on Emcure Pharma Shares Slip As Bain Capital Plans Rs 492.7 Crore Stake Sale - NDTV Profit

Emcure Pharma Shares Slip As Bain Capital Plans Rs 492.7 Crore Stake Sale  NDTV Profit

Emcure Pharma Shares Slip As Bain Capital Plans Rs 492.7 Crore Stake Sale - NDTV Profit

Click here to get full coverage on Emcure Pharma shares slip 5% amid large trades; check all details here - Business Standard

Emcure Pharma shares slip 5% amid large trades; check all details here  Business Standard

Emcure Pharma shares slip 5% amid large trades; check all details here - Business Standard

Click here to get full coverage on Novo Nordisk, Emcure to launch weight-loss drug under new brand in India - Reuters

Novo Nordisk, Emcure to launch weight-loss drug under new brand in India  Reuters

Novo Nordisk, Emcure to launch weight-loss drug under new brand in India - Reuters

Click here to get full coverage on Novo forges partnership with Emcure to expand Wegovy access in India - Fierce Pharma

Novo forges partnership with Emcure to expand Wegovy access in India  Fierce Pharma

Novo forges partnership with Emcure to expand Wegovy access in India - Fierce Pharma

Click here to get full coverage on Emcure Pharma Share Price Drop Nearly 5 Percent As Block Deal Overhang Weighs - HDFC Sky

Emcure Pharma Share Price Drop Nearly 5 Percent As Block Deal Overhang Weighs  HDFC Sky

Emcure Pharma Share Price Drop Nearly 5 Percent As Block Deal Overhang Weighs - HDFC Sky

Click here to get full coverage on Stocks to Watch: Paytm, Emcure Pharma, JSW Energy, HCLTech and more #StockMarket #stockmarketindia #StocksToTrade #StocksInFocus #StocksToFocus - LinkedIn

Stocks to Watch: Paytm, Emcure Pharma, JSW Energy, HCLTech and more #StockMarket #stockmarketindia #StocksToTrade #StocksInFocus #StocksToFocus  LinkedIn

Stocks to Watch: Paytm, Emcure Pharma, JSW Energy, HCLTech and more #StockMarket #stockmarketindia #StocksToTrade #StocksInFocus #StocksToFocus - LinkedIn

Click here to get full coverage on Emcure Pharma Block Deal | BC Investments plans 2% stake sale worth ₹493 crore - CNBC TV18

Emcure Pharma Block Deal | BC Investments plans 2% stake sale worth ₹493 crore  CNBC TV18

Emcure Pharma Block Deal | BC Investments plans 2% stake sale worth ₹493 crore - CNBC TV18

Click here to get full coverage on BC Investments to pare 2% stake in Emcure Pharma via block deal - India Infoline

BC Investments to pare 2% stake in Emcure Pharma via block deal  India Infoline

BC Investments to pare 2% stake in Emcure Pharma via block deal - India Infoline

Click here to get full coverage on Stocks to Watch Today: Physicswallah, Emmvee Photovoltaic, Emcure Pharma, WPIL, 5paisa Capital,... - Moneycontrol

Stocks to Watch Today: Physicswallah, Emmvee Photovoltaic, Emcure Pharma, WPIL, 5paisa Capital,...  Moneycontrol

Stocks to Watch Today: Physicswallah, Emmvee Photovoltaic, Emcure Pharma, WPIL, 5paisa Capital,... - Moneycontrol

Click here to get full coverage on Emcure Pharma shares slip up to 5% post block deals: 2.4% equity changes hands, says report - Upstox

Emcure Pharma shares slip up to 5% post block deals: 2.4% equity changes hands, says report  Upstox

Emcure Pharma shares slip up to 5% post block deals: 2.4% equity changes hands, says report - Upstox

Click here to get full coverage on Novo Nordisk Partners With Emcure To Launch Weight Loss Drug Poviztra In India - NDTV

Novo Nordisk Partners With Emcure To Launch Weight Loss Drug Poviztra In India  NDTV

Novo Nordisk Partners With Emcure To Launch Weight Loss Drug Poviztra In India - NDTV

Click here to get full coverage on Novo Nordisk bets on Emcure to win India’s weight-loss drug war - livemint.com

Novo Nordisk bets on Emcure to win India’s weight-loss drug war  livemint.com

Novo Nordisk bets on Emcure to win India’s weight-loss drug war - livemint.com

Click here to get full coverage on Emcure Pharmaceuticals Reports Strong Q2 Growth and Announces Strategic Partnership with Novo Nordisk - scanx.trade

Emcure Pharmaceuticals Reports Strong Q2 Growth and Announces Strategic Partnership with Novo Nordisk  scanx.trade

Emcure Pharmaceuticals Reports Strong Q2 Growth and Announces Strategic Partnership with Novo Nordisk - scanx.trade

Click here to get full coverage on Stocks To Watch: RIL, Paytm, Tata Power, HCL Tech, KPI Green, SJVN, Emcure Pharma, And Others - News18

Stocks To Watch: RIL, Paytm, Tata Power, HCL Tech, KPI Green, SJVN, Emcure Pharma, And Others  News18

Stocks To Watch: RIL, Paytm, Tata Power, HCL Tech, KPI Green, SJVN, Emcure Pharma, And Others - News18

Click here to get full coverage on Novo Nordisk partners with Emcure to launch weight-loss drug under new brand in India - The Economic Times

Novo Nordisk partners with Emcure to launch weight-loss drug under new brand in India  The Economic Times

Novo Nordisk partners with Emcure to launch weight-loss drug under new brand in India - The Economic Times

Click here to get full coverage on Emcure Pharma Block Deal: Bain Capital To Offload Shares Worth Nearly Rs 500 Crore - NDTV Profit

Emcure Pharma Block Deal: Bain Capital To Offload Shares Worth Nearly Rs 500 Crore  NDTV Profit

Emcure Pharma Block Deal: Bain Capital To Offload Shares Worth Nearly Rs 500 Crore - NDTV Profit

Click here to get full coverage on Stock Alert: WPIL, Emcure Pharma, JSW Energy, Tata Power, AstraZeneca Pharma India - Business Standard

Stock Alert: WPIL, Emcure Pharma, JSW Energy, Tata Power, AstraZeneca Pharma India  Business Standard

Stock Alert: WPIL, Emcure Pharma, JSW Energy, Tata Power, AstraZeneca Pharma India - Business Standard

Click here to get full coverage on Stocks to Watch: Paytm, Emcure Pharma, JSW Energy, HCLTech and more - CNBC TV18

Stocks to Watch: Paytm, Emcure Pharma, JSW Energy, HCLTech and more  CNBC TV18

Stocks to Watch: Paytm, Emcure Pharma, JSW Energy, HCLTech and more - CNBC TV18

Click here to get full coverage on Emcure eyes to build Brand loyalty with Semaglutide ahead of generics flood - ET Pharma

Emcure eyes to build Brand loyalty with Semaglutide ahead of generics flood  ET Pharma

Emcure eyes to build Brand loyalty with Semaglutide ahead of generics flood - ET Pharma

Click here to get full coverage on Emcure Pharmace Consolidated September 2025 Net Sales at Rs 2,269.82 crore, up 13.38% Y-o-Y - Moneycontrol

Emcure Pharmace Consolidated September 2025 Net Sales at Rs 2,269.82 crore, up 13.38% Y-o-Y  Moneycontrol

Emcure Pharmace Consolidated September 2025 Net Sales at Rs 2,269.82 crore, up 13.38% Y-o-Y - Moneycontrol

Click here to get full coverage on Emcure Pharmaceuticals Limited (NSE:EMCURE) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year - simplywall.st

Emcure Pharmaceuticals Limited (NSE:EMCURE) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year  simplywall.st

Emcure Pharmaceuticals Limited (NSE:EMCURE) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year - simplywall.st

Click here to get full coverage on Stocks to Watch Today (November 18, 2025): Paytm, Mphasis, Emcure Pharma, Hyundai Motors India, MGL and more - Zee Business

Stocks to Watch Today (November 18, 2025): Paytm, Mphasis, Emcure Pharma, Hyundai Motors India, MGL and more  Zee Business

Stocks to Watch Today (November 18, 2025): Paytm, Mphasis, Emcure Pharma, Hyundai Motors India, MGL and more - Zee Business

Click here to get full coverage on Novo-Emcure Semaglutide Deal Clever Counter To Indian Rivals, Follows Lilly-Cipla Pact - Citeline News & Insights

Novo-Emcure Semaglutide Deal Clever Counter To Indian Rivals, Follows Lilly-Cipla Pact  Citeline News & Insights

Novo-Emcure Semaglutide Deal Clever Counter To Indian Rivals, Follows Lilly-Cipla Pact - Citeline News & Insights

Click here to get full coverage on Stocks To Watch Today: Paytm, Mphasis, JSW Energy | 18 Nov - Samco

Stocks To Watch Today: Paytm, Mphasis, JSW Energy | 18 Nov  Samco

Stocks To Watch Today: Paytm, Mphasis, JSW Energy | 18 Nov - Samco

Click here to get full coverage on Emcure seals distribution pact with Novo Nordisk for weight-loss drug Semaglutide second brand - ET Pharma

Emcure seals distribution pact with Novo Nordisk for weight-loss drug Semaglutide second brand  ET Pharma

Emcure seals distribution pact with Novo Nordisk for weight-loss drug Semaglutide second brand - ET Pharma

Click here to get full coverage on Novo Nordisk India partners with Emcure to launch weight loss drug Poviztra - Healthcare Radius

Novo Nordisk India partners with Emcure to launch weight loss drug Poviztra  Healthcare Radius

Novo Nordisk India partners with Emcure to launch weight loss drug Poviztra - Healthcare Radius

Click here to get full coverage on Novo Nordisk ropes in Emcure Pharma to roll out weight loss drug Poviztra - The Hindu

Novo Nordisk ropes in Emcure Pharma to roll out weight loss drug Poviztra  The Hindu

Novo Nordisk ropes in Emcure Pharma to roll out weight loss drug Poviztra - The Hindu

Click here to get full coverage on Novo Nordisk, Emcure Pharma to launch weight-loss drug under new brand - Business Standard

Novo Nordisk, Emcure Pharma to launch weight-loss drug under new brand  Business Standard

Novo Nordisk, Emcure Pharma to launch weight-loss drug under new brand - Business Standard

Click here to get full coverage on Emcure Pharmaceuticals Reports Robust Growth in Q2 FY2025 - Machine Maker

Emcure Pharmaceuticals Reports Robust Growth in Q2 FY2025  Machine Maker

Emcure Pharmaceuticals Reports Robust Growth in Q2 FY2025 - Machine Maker

Click here to get full coverage on Emcure Pharmaceuticals Reports Strong Q2 FY2025 Performance - BW Healthcare World

Emcure Pharmaceuticals Reports Strong Q2 FY2025 Performance  BW Healthcare World

Emcure Pharmaceuticals Reports Strong Q2 FY2025 Performance - BW Healthcare World

Click here to get full coverage on Should You Average Down on Emcure Pharmaceuticals Limited Stock - Low Beta Stocks & Maximum Profit Growth - earlytimes.in

Should You Average Down on Emcure Pharmaceuticals Limited Stock - Low Beta Stocks & Maximum Profit Growth  earlytimes.in

Should You Average Down on Emcure Pharmaceuticals Limited Stock - Low Beta Stocks & Maximum Profit Growth - earlytimes.in

Click here to get full coverage on EMCURE PHARMACEUTICALS LTD. Share Price Today Up 5% - Equitymaster

EMCURE PHARMACEUTICALS LTD. Share Price Today Up 5%  Equitymaster

EMCURE PHARMACEUTICALS LTD. Share Price Today Up 5% - Equitymaster

Click here to get full coverage on Novo Nordisk, Emcure to launch WeGovy weight-loss drug under new brand in India | Business News - Hindustan Times

Novo Nordisk, Emcure to launch WeGovy weight-loss drug under new brand in India | Business News  Hindustan Times

Novo Nordisk, Emcure to launch WeGovy weight-loss drug under new brand in India | Business News - Hindustan Times

Click here to get full coverage on Will Market Volatility Create Buying Opportunities for Emcure Pharmaceuticals Limited - Retail Investor Activity & Master Technical Analysis With Free Tools - earlytimes.in

Will Market Volatility Create Buying Opportunities for Emcure Pharmaceuticals Limited - Retail Investor Activity & Master Technical Analysis With Free Tools  earlytimes.in

Will Market Volatility Create Buying Opportunities for Emcure Pharmaceuticals Limited - Retail Investor Activity & Master Technical Analysis With Free Tools - earlytimes.in

Click here to get full coverage on Key facts: Novo Nordisk's weight-loss drugs yield results; shares up 3.5%; partners with Emcure - TradingView

Key facts: Novo Nordisk's weight-loss drugs yield results; shares up 3.5%; partners with Emcure  TradingView

Key facts: Novo Nordisk's weight-loss drugs yield results; shares up 3.5%; partners with Emcure - TradingView

Click here to get full coverage on India’s booming weight-loss drug market is making big moves! After the success of it's weight-loss drug Wegovy, Novo Nordisk India has tied up with Emcure Pharmaceuticals to launch another weight-loss drug, Poviztra. Ekta Batra brings you more details #We - LinkedIn

India’s booming weight-loss drug market is making big moves! After the success of it's weight-loss drug Wegovy, Novo Nordisk India has tied up with Emcure Pharmaceuticals to launch another weight-loss drug, Poviztra. Ekta Batra brings you more details #We  LinkedIn

India’s booming weight-loss drug market is making big moves! After the success of it's weight-loss drug Wegovy, Novo Nordisk India has tied up with Emcure Pharmaceuticals to launch another weight-loss drug, Poviztra. Ekta Batra brings you more details #We - LinkedIn

Click here to get full coverage on Novo Nordisk ties up with Emcure for India launch of weight-management injection Poviztra - ET Manufacturing

Novo Nordisk ties up with Emcure for India launch of weight-management injection Poviztra  ET Manufacturing

Novo Nordisk ties up with Emcure for India launch of weight-management injection Poviztra - ET Manufacturing

Click here to get full coverage on Emcure Pharma Partners With Novo Nordisk To Launch Weight Loss Injection In India - NDTV Profit

Emcure Pharma Partners With Novo Nordisk To Launch Weight Loss Injection In India  NDTV Profit

Emcure Pharma Partners With Novo Nordisk To Launch Weight Loss Injection In India - NDTV Profit

Click here to get full coverage on Novo Nordisk partners Emcure Pharma to commercialise weight loss drug Poviztra in India - financialexpress.com

Novo Nordisk partners Emcure Pharma to commercialise weight loss drug Poviztra in India  financialexpress.com

Novo Nordisk partners Emcure Pharma to commercialise weight loss drug Poviztra in India - financialexpress.com

Click here to get full coverage on Emcure Pharma Q2 profit rises 25%, revenue up 13% on broad-based growth - The Economic Times

Emcure Pharma Q2 profit rises 25%, revenue up 13% on broad-based growth  The Economic Times

Emcure Pharma Q2 profit rises 25%, revenue up 13% on broad-based growth - The Economic Times

Click here to get full coverage on Emcure shares jump 8% on Novo Nordisk tie-up to launch weight-loss drug in India - CNBC TV18

Emcure shares jump 8% on Novo Nordisk tie-up to launch weight-loss drug in India  CNBC TV18

Emcure shares jump 8% on Novo Nordisk tie-up to launch weight-loss drug in India - CNBC TV18

Click here to get full coverage on Emcure Pharmaceuticals rises on BOB Capital's bullish initiation, Sanofi tie-up - TradingView

Emcure Pharmaceuticals rises on BOB Capital's bullish initiation, Sanofi tie-up  TradingView

Emcure Pharmaceuticals rises on BOB Capital's bullish initiation, Sanofi tie-up - TradingView

Click here to get full coverage on Emcure Pharmace Standalone September 2025 Net Sales at Rs 1,260.60 crore, up 14.12% Y-o-Y - Moneycontrol

Emcure Pharmace Standalone September 2025 Net Sales at Rs 1,260.60 crore, up 14.12% Y-o-Y  Moneycontrol

Emcure Pharmace Standalone September 2025 Net Sales at Rs 1,260.60 crore, up 14.12% Y-o-Y - Moneycontrol

Click here to get full coverage on Novo Nordisk Picks Emcure Pharma for Distribution of its Weight Loss Injection - outlookbusiness.com

Novo Nordisk Picks Emcure Pharma for Distribution of its Weight Loss Injection  outlookbusiness.com

Novo Nordisk Picks Emcure Pharma for Distribution of its Weight Loss Injection - outlookbusiness.com

Click here to get full coverage on Novo Nordisk India And Emcure Pharma Partner To Launch Poviztra For Weight Management In India - BW Healthcare World

Novo Nordisk India And Emcure Pharma Partner To Launch Poviztra For Weight Management In India  BW Healthcare World

Novo Nordisk India And Emcure Pharma Partner To Launch Poviztra For Weight Management In India - BW Healthcare World

Click here to get full coverage on Novo Nordisk Teams Up with Emcure to Launch Weight Loss Drug Poviztra in India - Chemical Industry Digest

Novo Nordisk Teams Up with Emcure to Launch Weight Loss Drug Poviztra in India  Chemical Industry Digest

Novo Nordisk Teams Up with Emcure to Launch Weight Loss Drug Poviztra in India - Chemical Industry Digest

Click here to get full coverage on Why Emcure Pharmaceuticals Limited Stock May Be a Hidden Gem in YEAR - Volume Profile Analysis & Minimal Investment Capital Gains - earlytimes.in

Why Emcure Pharmaceuticals Limited Stock May Be a Hidden Gem in YEAR - Volume Profile Analysis & Minimal Investment Capital Gains  earlytimes.in

Why Emcure Pharmaceuticals Limited Stock May Be a Hidden Gem in YEAR - Volume Profile Analysis & Minimal Investment Capital Gains - earlytimes.in

Click here to get full coverage on Novo, Emcure to launch weight-loss drug under new brand in India - The Economic Times

Novo, Emcure to launch weight-loss drug under new brand in India  The Economic Times

Novo, Emcure to launch weight-loss drug under new brand in India - The Economic Times

Click here to get full coverage on Novo Nordisk India joins hands with Emcure Pharma to introduce Poviztra® - Machine Maker

Novo Nordisk India joins hands with Emcure Pharma to introduce Poviztra®  Machine Maker

Novo Nordisk India joins hands with Emcure Pharma to introduce Poviztra® - Machine Maker

Click here to get full coverage on Emcure’s Emcutix unveils AquaOat range for eczema relief - Healthcare Radius

Emcure’s Emcutix unveils AquaOat range for eczema relief  Healthcare Radius

Emcure’s Emcutix unveils AquaOat range for eczema relief - Healthcare Radius

Click here to get full coverage on Emcure Pharma reports 25 percent surge in profit after tax to Rs 251 crore in Q2 - Medical Dialogues

Emcure Pharma reports 25 percent surge in profit after tax to Rs 251 crore in Q2  Medical Dialogues

Emcure Pharma reports 25 percent surge in profit after tax to Rs 251 crore in Q2 - Medical Dialogues

Click here to get full coverage on Novo Nordisk India Partners with Emcure Pharma to Launch Poviztra for Weight Management - Sahyadri Startups

Novo Nordisk India Partners with Emcure Pharma to Launch Poviztra for Weight Management  Sahyadri Startups

Novo Nordisk India Partners with Emcure Pharma to Launch Poviztra for Weight Management - Sahyadri Startups

Click here to get full coverage on Novo Nordisk partners with Emcure to launch weight loss drug semaglutide under Poviztra brand in India - Fortune India

Novo Nordisk partners with Emcure to launch weight loss drug semaglutide under Poviztra brand in India  Fortune India

EMCURE

Price Chart

Key Statistics

Technicals

About EMCURE

Latest News

India's Emcure Pharmaceuticals drops after block deals at discount - TradingView

Emcure Pharma Shares Slip As Bain Capital Plans Rs 492.7 Crore Stake Sale - NDTV Profit

Emcure Pharma shares slip 5% amid large trades; check all details here - Business Standard

Advanced Charts

Top Gainers

Top Losers